1-2 of 2
Christian Rübe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL

Clinical Trials & Observations
Michael Pfreundschuh, Lorenz Trümper, Marita Kloess, Rudolf Schmits, Alfred C. Feller, Christian Rudolph, Marcel Reiser, Dieter K. Hossfeld, Bernd Metzner, Dirk Hasenclever, Norbert Schmitz, Bertram Glass, Christian Rübe, Markus Loeffler, the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Journal: Blood
Blood (2004) 104 (3): 626–633.
https://doi.org/10.1182/blood-2003-06-2094
Published: 2004
Journal Articles

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

Clinical Trials & Observations
Michael Pfreundschuh, Lorenz Trümper, Marita Kloess, Rudolf Schmits, Alfred C. Feller, Christian Rübe, Christian Rudolph, Marcel Reiser, Dieter K. Hossfeld, Hartmut Eimermacher, Dirk Hasenclever, Norbert Schmitz, Markus Loeffler, the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Journal: Blood
Blood (2004) 104 (3): 634–641.
https://doi.org/10.1182/blood-2003-06-2095
Published: 2004